BioLineRx Ltd. (TLV: BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3.500
-0.200 (-5.41%)
Jan 19, 2025, 3:49 PM IDT

BioLineRx Market Cap

BioLineRx has a market cap or net worth of 79.00 million as of January 22, 2025. Its market cap has decreased by -80.91% in one year.

Market Cap
79.00M
Enterprise Value
80.64M
Revenue
81.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.50

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 79.00M, an increase of 48,358.07%. That is a compound annual growth rate of 41.12%.

History

DateMarket Cap% Change
Jan 21, 202579.00M-7.65%
Dec 31, 202485.55M-79.39%
Dec 31, 2023415.08M314.57%
Dec 29, 2022100.12M-67.59%
Dec 30, 2021308.95M60.58%
Dec 31, 2020192.39M108.80%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 31, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 88.56B
Danel (Adir Yeoshua) 2.53B
Kamada 1.45B
Bait Bakfar 1.05B
Novolog (Pharm-Up 1966) 973.94M
Ilex Medical 834.54M
BrainsWay 710.39M
SofWave Medical 603.50M
Market Cap Rankings